AN OPEN LABEL CLINICAL TRIAL OF RETINAL GENE THERAPY FOR CHOROIDEREMIA USING AN ADENO-ASSOCIATED VIRAL VECTOR (AAV2) ENCODING RAB-ESCORT PROTEIN-1 (REP-1)

Registry ID

PR-0001.1

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

UNIVERSITY OF ALBERTA

Start date

2015-04-10

Last update

2013-08-30

Conditions

• CHOROIDEREMIA

Related clinical trials

• A LONG-TERM FOLLOW-UP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF RETINAL GENE THERAPY IN SUBJECTS WITH CHOROIDEREMIA TREATED PREVIOUSLY WITH ADENO-ASSOCIATED VIRAL VECTOR ENCODING RAB ESCORT PROTEIN-1 (AAV2-REP1) IN AN ANTECEDENT STUDY

View on source registry